Johan E Larsson
Overview
Explore the profile of Johan E Larsson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ali S, Vinding N, Butt J, Kroll J, Larsson J, Schou M, et al.
JACC Heart Fail
. 2025 Feb;
13(3):483-493.
PMID: 39918535
Background: Worldwide, major health care variations exist in patients with heart failure (HF). Objectives: In this study, the authors sought to examine and compare immigrants grouped by region of origin...
2.
Larsson J, Crespo-Leiro M, Gustafsson F
JACC Heart Fail
. 2025 Feb;
13(2):248-252.
PMID: 39909637
No abstract available.
3.
Larsson J, Kristensen S, Deis T, Warming P, Schou M, Kober L, et al.
ESC Heart Fail
. 2024 Sep;
12(1):477-486.
PMID: 39344872
Aims: Socioeconomic deprivation is a risk marker for worse prognosis in patients with heart failure (HF), and a potential barrier to referral for advanced HF evaluation. The relationship between socioeconomic...
4.
Schjodt I, Mols R, Bakos I, Horvath-Puho E, Gustafsson F, Kristensen S, et al.
ESC Heart Fail
. 2024 Mar;
11(4):1919-1931.
PMID: 38488159
Aims: Increasing numbers of patients with advanced heart failure and significant comorbidity and social barriers are considered for left ventricular assist devices (LVADs). We sought to examine health care utilization...
5.
Larsson J, Kristensen S, Deis T, Warming P, Graversen P, Schou M, et al.
J Heart Lung Transplant
. 2024 Feb;
43(6):920-930.
PMID: 38408549
Background: Socioeconomic deprivation is associated with a lower likelihood of referral for advanced heart failure (HF) evaluation, but it is not known whether it influences rates of advanced HF therapies...
6.
Schjodt I, Mols R, Eiskjaer H, Bakos I, Horvath-Puho E, Gustafsson F, et al.
ASAIO J
. 2023 Oct;
69(12):e482-e490.
PMID: 37792681
The use of a left ventricular assist device (LVAD) in treating advanced heart failure has increased. However, data regarding medical treatment and adherence following LVAD implantation is sparse, particularly whether...
7.
Larsson J, Denholt C, Thune J, Raja A, Fosbol E, Schou M, et al.
Eur Heart J Cardiovasc Pharmacother
. 2023 Jun;
9(6):546-552.
PMID: 37355774
Background: The mineralocorticoid receptor antagonists (MRAs) eplerenone and spironolactone are beneficial in heart failure with reduced ejection fraction (HFrEF), but have not been prospectively compared. We compared clinical outcomes, daily...
8.
Schonemann-Lund M, Itenov T, Larsson J, Lindegaard B, Johansson P, Bestle M
Acta Anaesthesiol Scand
. 2023 Apr;
67(7):896-908.
PMID: 37042167
Baseline levels of endotheliopathy are associated with worse respiratory outcomes and mortality in undifferentiated acute respiratory failure (ARF), but knowledge is lacking on the development of endotheliopathy over time in...
9.
Schonemann-Lund M, Itenov T, Larsson J, Lindegaard B, Johansson P, Bestle M
Crit Care
. 2022 Jan;
26(1):33.
PMID: 35094711
Background: Endotheliopathy is suggested as pivotal pathophysiology of sepsis and trauma-associated organ failure, but its role in acute respiratory failure is not yet determined. We investigated if endotheliopathy biomarkers at...
10.
Larsson J, Frampton D, Liin S
Front Physiol
. 2020 Jun;
11:641.
PMID: 32595524
Voltage-gated potassium channels of the K7 family are expressed in many tissues. The physiological importance of K7 channels is evident from specific forms of disorders linked to dysfunctional K7 channels,...